GRI Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Cash & Equivalents	1.81	0.01	3.7	0.11	3.82	0.61
Short-Term Investments	0	0	3.81	0	0	0
Cash & Cash Equivalents	1.81	0.01	7.51	0.11	3.82	0.61
Cash Growth	19988.89%	-99.88%	6789.91%	-97.15%	523.68%	-
Other Current Assets	1.13	0.3	0.62	0.57	0.1	0.02
Total Current Assets	2.93	0.31	8.13	0.67	3.92	0.64
Property, Plant & Equipment	0.02	0.07	0	0	0.35	0
Other Long-Term Assets	0	0	0.21	0.28	0	0
Total Long-Term Assets	0.02	0.07	0.21	0.28	0.35	0
Total Assets	2.96	0.38	8.34	0.96	4.28	0.64
Accounts Payable	1.41	1.29	0.92	1.23	0.25	0.29
Current Debt	0.01	0.66	0	0.05	0.09	0
Other Current Liabilities	1.27	0.04	1.53	0.95	0.48	0.2
Total Current Liabilities	2.7	1.99	2.45	2.23	0.81	0.49
Long-Term Debt	0	0.01	0	0.01	0.25	0
Other Long-Term Liabilities	0	0	0.07	0.17	0	0
Total Long-Term Liabilities	0	0.01	0.07	0.18	0.25	0
Total Liabilities	2.7	2.01	2.52	2.41	1.06	0.49
Total Debt	0.01	0.68	0	0.06	0.34	0
Debt Growth	-97.94%	-	-	-82.06%	-	-
Retained Earnings	-31.53	-18.5	-21.9	-12.6	-7.78	-4.31
Comprehensive Income	0	0	-0	0	0	0
Shareholders' Equity	0.26	-1.63	5.82	-1.45	3.21	0.15
Net Cash / Debt	1.79	-0.67	7.51	0.05	3.48	0.61
Net Cash / Debt Growth	-	-	15545.83%	-98.62%	468.19%	-
Net Cash Per Share	3.89	-5.19	241.11	2.24	205.90	80.33
Working Capital	0.24	-1.68	5.68	-1.55	3.11	0.15
Book Value Per Share	0.56	-12.60	186.79	-67.76	190.11	20.05

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).